![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/428 | (2006.01) |
A61K 31/427 | (2006.01) | ||
A61K 31/4985 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
C07D 277/82 | (2006.01) | ||
C07D 417/12 | (2006.01) | ||
A61K 9/48 | (2006.01) | ||
A61K 9/20 | (2006.01) | ||
A61P 25/14 | (2006.01) |
(11) | Number of the document | 3706739 |
(13) | Kind of document | T |
(96) | European patent application number | 18876779.2 |
Date of filing the European patent application | 2018-11-11 | |
(97) | Date of publication of the European application | 2020-09-16 |
(45) | Date of publication and mention of the grant of the patent | 2024-10-16 |
(46) | Date of publication of the claims translation | 2024-12-27 |
(86) | Number | PCT/US2018/060232 |
Date | 2018-11-11 |
(87) | Number | WO 2019/094851 |
Date | 2019-05-16 |
(30) | Number | Date | Country code |
201762584856 P | 2017-11-12 | US | |
201862717948 P | 2018-08-13 | US |
(72) |
CORIC, Vladimir , US
BERMAN, Robert , US
BEINER, Melissa , US
L'ITALIEN, Gilbert , US
|
(73) |
Biohaven Therapeutics Ltd. ,
215 Church Street, New Haven, CT 06510,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Riluzolo provaisto naudojimas ataksijų gydymui |
USE OF RILUZOLE PRODRUGS TO TREAT ATAXIAS |
Payment date | Validity (years) | Amount | |
2024-11-07 | 7 | 162.00 EUR |
2025-11-11 |